Showing results (311-320 of 500) with videos related to
Sort By:
Pageof 50
Journal of Neuro-Oncology|May 12, 2009
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannomaScott R Plotkin, Chris Halpin, Jaishri O Blakeley, et al.Neuro-Oncology|February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomasS Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.Nature Communications|September 16, 2022
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancerCarter J Barger, Abigail K Suwala, Katarzyna M Soczek, et al.Journal of Neurosurgery|December 15, 2010
Impact of bevacizumab chemotherapy on craniotomy wound healingAaron J Clark, Nicholas A Butowski, Susan M Chang, et al.Journal of Neurosurgery|March 10, 2009
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical articleEdward F Chang, Aaron Clark, Randy L Jensen, et al.Neuro-Oncology|August 19, 2024
Enhancing neuro-oncology care through equity-driven applications of artificial intelligenceMulki Mehari, Youssef Sibih, Abraham Dada, et al.Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology GuidelineErik P Sulman, Nofisat Ismaila, Terri S Armstrong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone proteinCourtney A Crane, Seunggu J Han, Brian Ahn, et al.Pageof 50